x
Benefiting society through translational research
The University of Illinois at Chicago (UIC) is collaborating with Deerfield Management to accelerate the commercialization of therapeutics developed at UIC. West Loop Innovations will support UIC's innovative translational research and leverage Deerfield's expertise in accelerating state-of-the-art drug development.
West Loop-funded projects aim to cure life-altering diseases with novel therapeutics. Deerfield will invest up to $65 million in translational research funding to advance promising UIC discoveries.
Selected projects, vetted through a joint steering committee, are funded by Deerfield through West Loop and executed by a collaborative team of university scientists and Deerfield experts.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
As Chicago's only public research university and one with a Carnegie 1 Research designation, UIC is a hub of innovation and cutting-edge research with a commitment to discovery and solving real-world problems. UIC is a leader in translational medicine and has a proven track record of commercializing therapeutics with three major drugs in the market today. Visit us at www.uic.edu.
Proposal Submissions
To learn more about project sourcing and evaluation, please reach out to West Loop Innovations Scientific Collaboration Manager Melissa Maderia at maderia@otm.uic.edu.
Updates from Cure.
Cure. is a Deerfield affiliate and premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop groundbreaking products and services from concept to commercialization.
Content is generated and provided by third parties, including Cure, an affiliate of West Loop and Deerfield, and has not been reviewed or approved by West Loop or Deerfield.